These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26220528)

  • 1. Inhibition of eosinophil apoptosis by asthma-relevant cytokines from platelets.
    Varadharajan V
    J Allergy Clin Immunol; 2015 Oct; 136(4):1134. PubMed ID: 26220528
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelets in patients with aspirin-exacerbated respiratory disease.
    Laidlaw TM; Boyce JA
    J Allergy Clin Immunol; 2015 Jun; 135(6):1407-14; quiz 1415. PubMed ID: 26051947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. With age comes wisdom: is this true for platelets?
    Bonello L; Frère C; Paganelli F; Laine M
    J Am Coll Cardiol; 2014 Feb; 63(6):518-9. PubMed ID: 24184236
    [No Abstract]   [Full Text] [Related]  

  • 4. Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.
    Deharo P; Pankert M; Bonnet G; Quilici J; Bassez C; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Int J Cardiol; 2014 Oct; 176(3):1200-2. PubMed ID: 25156857
    [No Abstract]   [Full Text] [Related]  

  • 5. Response variability and the role of platelet function testing.
    Gurbel PA; Mahla E; Antonino MJ; Tantry US
    J Invasive Cardiol; 2009 Apr; 21(4):172-8. PubMed ID: 19342756
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs: retapamulin, bismuth subcitrate potassium, and rotigotine.
    Hussar DA
    J Am Pharm Assoc (2003); 2007; 47(4):539-43. PubMed ID: 17616504
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.
    Cuisset T; Cayla G; Quilici J; Pankert M; Deharo P; Bonnet G; Grosdidier C; Beguin S; Morange P; Bonnet JL; Alessi MC
    Int J Cardiol; 2013 Oct; 168(3):2988-9. PubMed ID: 23642612
    [No Abstract]   [Full Text] [Related]  

  • 8. Another view on prasugrel.
    Calatzis A
    Thromb Haemost; 2009 Jan; 101(1):12-3. PubMed ID: 19132183
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet inhibition with prasugrel and increased cancer risks: potential causes and implications.
    Serebruany VL
    Am J Med; 2009 May; 122(5):407-8. PubMed ID: 19375544
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to letter regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction".
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos K; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2013 Apr; 6(2):e29. PubMed ID: 23591428
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter by Grove and Kristensen regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction".
    Grove EL; Kristensen SD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):e28. PubMed ID: 23591427
    [No Abstract]   [Full Text] [Related]  

  • 12. The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils.
    Jawień J; Lomnicka M; Korbut R; Chłopicki S
    J Physiol Pharmacol; 2005 Dec; 56(4):637-48. PubMed ID: 16391420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pursuit of clinically relevant measures of platelet function after antiplatelet drug therapy.
    Cairns JA; Eikelboom J
    J Am Coll Cardiol; 2008 Dec; 52(24):1978-80. PubMed ID: 19055988
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of blood platelets & circulating eosinophils following administration of 5-hydroxytryptamine in a single dose in the rat].
    SERRA U; BRUNI G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1957 Dec; 10(6):657-64. PubMed ID: 13512405
    [No Abstract]   [Full Text] [Related]  

  • 15. Warm-up exercise suppresses platelet-eosinophil/neutrophil aggregation and platelet-promoted release of eosinophil/neutrophil oxidant products enhanced by severe exercise in men.
    Wang JS; Yen HL; Yang CM
    Thromb Haemost; 2006 Mar; 95(3):490-8. PubMed ID: 16525578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related cardioprotection by ifetroban in relation to inhibition of thrombosis and ex vivo platelet function.
    Gomoll AW; Schumacher WA; Ogletree ML
    Pharmacology; 1995 Feb; 50(2):92-110. PubMed ID: 7716179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer antiarrhythmic drugs.
    Gupta AK; Maheshwari A; Thakur RK; Lokhandwala YY
    Indian Heart J; 2001; 53(3):354-60. PubMed ID: 11516042
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids.
    Misra A; Anil Kumar KS; Jain M; Bajaj K; Shandilya S; Srivastava S; Shukla P; Barthwal MK; Dikshit M; Dikshit DK
    Eur J Med Chem; 2016 Mar; 110():1-12. PubMed ID: 26807542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine and cytokine production and apoptosis of human eosinophils.
    Hasala H; Janka-Junttila M; Moilanen E; Kankaanranta H
    Allergy Asthma Proc; 2007; 28(5):582-91. PubMed ID: 18034979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
    Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
    Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.